Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Details Narrative)

v3.22.2.2
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 10, 2022
Mar. 15, 2022
Jul. 16, 2021
Mar. 15, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 14, 2022
Dec. 31, 2021
Nov. 05, 2021
Nov. 04, 2021
Reverse stock split   1-for-10,000 1-for-1,000                  
Reverse stock splits, shares     1,000 10,000                
Common stock, shares authorized   250,000,000,000     250,000,000,000   250,000,000,000   50,000,000,000 250,000,000,000 50,000,000,000 10,000,000,000
Net revenue, reduced         $ 2,825,937 $ 1,010,245 $ 7,576,693 $ 1,288,402        
Estimated contractual allowances         10,200,000 6,800,000 23,400,000 16,200,000        
Accounts Receivable, Credit Loss Expense (Reversal)         1,600,000 1,900,000 5,700,000 6,200,000        
Allowance for adjustment of revenue         11,800,000 8,700,000 29,100,000 22,400,000        
Revenues         2,800,000 1,000,000.0 7,600,000 1,300,000        
Deemed dividend         5,400,000              
Warrant modification trigger, value           253,500,000            
Deemed dividends from issuance of warrants under exchange agreement           $ 300,000   300,000        
Series P Convertible Preferred Stock [Member]                        
Deemed dividend         300,000   300,000          
Medicare [Member]                        
Net revenue, reduced         1,600,000   1,600,000          
Revenues         $ 1,600,000              
Subsequent Event [Member]                        
Net revenue, reduced $ 1,900,000                      
Common Stock [Member]                        
Reverse stock split       every 10,000 shares of the Company’s common stock then outstanding was combined and automatically converted into one share of the Company’s common stock on March 15, 2022.                
Warrant [Member]                        
Deemed dividend             $ 330,600,000 $ 403,100,000